Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer

Clinical trial NCT06653023 · SUSPENDED

Trial details

NCT number: NCT06653023
Sponsor: Wondercel Biotech (ShenZhen)
Status: SUSPENDED
Phase: Early Phase 1
Study type: INTERVENTIONAL

HCC - Hepatocellular Carcinoma NSCLC (Advanced Non-small Cell Lung Cancer)

Start date: 2024-10-23
Primary completion: 2027-10-20
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.